Chr | chr21 |
start | 40383083 |
end | 40385358 |
lncRNA name | DSCAM-AS1 |
entrez id | 100506492 |
hgnc id | HGNC:40197 |
ensg id | ENSG00000235123 |
refseq id | NR_038896 |
methods | RNA-seq, qPCR, RNAi, RIP, ChIP, Cell proliferation assay etc. |
regulated | up-regulated |
function description | Among the luminal breast cancers, DSCAM-AS1 is expressed significantly higher in luminal B, a clinical subtype containing most of the clinically aggressive ER-positive breast cancers. We demonstrate that DSCAM-AS1 mediates tumour progression and tamoxifen resistance and identify hnRNPL as an interacting protein involved in the mechanism of DSCAM-AS1 action. |
pubmed id | 27666543 |
year | 2016 |
title | The lncRNA landscape of breast cancer reveals a role for DSCAM-AS1 in breast cancer progression. |
drug | V |
circulating | X |
survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China